Evidence map›Paper›PMID 35110611›Full record

ArticleScientific reports2022

Differentiation of intestinal tuberculosis and Crohn's disease through an explainable machine learning method.

Futian Weng, Yu Meng, Fanggen Lu, Yuying Wang, Weiwei Wang, Long Xu, Dongsheng Cheng, Jianping Zhu

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Urinary lipoarabinomannan for gastrointestinal tuberculosis: Another tool in the kit.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Futian Weng *School of Medicine, Xiamen University, Xiamen, 361005, Fujian, China.
Yu Meng *Department of Gastroenterology and Hepatology, Shenzhen University General Hospital, Shenzhen, 518055, China.
Fanggen LuThe Gastroenterology Department of Second Xiangya Hospital, Central South University, Changsha, 410011, China.
Yuying WangData Mining Research Center, Xiamen University, Xiamen, 361005, Fujian, China.
Weiwei WangSchool of Medicine, Xiamen University, Xiamen, 361005, Fujian, China.
Long XuDepartment of Gastroenterology and Hepatology, Shenzhen University General Hospital, Shenzhen, 518055, China.
Dongsheng ChengSchool of Software Engineering, Shenzhen Institute of Information Technology, Shenzhen, 518172, China.
Jianping ZhuNational Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, 361005, Fujian, China. xmjpzhu@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differentiation between Crohn's disease and intestinal tuberculosis is difficult but crucial for medical decisions. This study aims to develop an effective framework to distinguish these two diseases through an explainable machine learning (ML) model. After feature selection, a total of nine variables are extracted, including intestinal surgery, abdominal, bloody stool, PPD, knot, ESAT-6, CFP-10, intestinal dilatation and comb sign. Besides, we compared the predictive performance of the ML methods with traditional statistical methods. This work also provides insights into the ML model's outcome through the SHAP method for the first time. A cohort consisting of 200 patients' data (CD = 160, ITB = 40) is used in training and validating models. Results illustrate that the XGBoost algorithm outperforms other classifiers in terms of area under the receiver operating characteristic curve (AUC), sensitivity, specificity, precision and Matthews correlation coefficient (MCC), yielding values of 0.891, 0.813, 0.969, 0.867 and 0.801 respectively. More importantly, the prediction outcomes of XGBoost can be effectively explained through the SHAP method. The proposed framework proves that the effectiveness of distinguishing CD from ITB through interpretable machine learning, which can obtain a global explanation but also an explanation for individual patients.

Indexed as

Decision Support TechniquesDiagnosis, Computer-AssistedMachine LearningAdultCrohn DiseaseDiagnosis, DifferentialFemaleHumansMaleMiddle AgedPredictive Value of TestsTuberculosis, GastrointestinalYoung Adult

Identifiers

PMID35110611
PMCPMC8810833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.